Public, NASDAQ:NFLD
NASDAQ Global Market
Northfield Laboratories files BLA for PolyHeme
Date: Sat, 01 Nov 2008 02:05:18 GMT
Tags:
Northfield Laboratories files BLA for PolyHeme
Pharmaceutical Business Review - Nov 1, 2008
Pharmaceutical Business Review - Nov 1, 2008
By Staff Writer The company has also requested priority review, based on the potential for PolyHeme to address a critical, unmet medical need. By regulation, the FDA has 60 calendar days to review ...
Northfield seeks FDA priority review of blood substitute
Date: Thu, 30 Oct 2008 16:04:00 GMT
Tags:
Northfield seeks FDA priority review of blood substitute
SmartBrief - Oct 30, 2008
SmartBrief - Oct 30, 2008
Northfield Laboratories filed for FDA priority evaluation of PolyHeme, an investigational blood substitute. The company submitted its request despite data from a clinical trial last year showing ...
Northfield seeks FDA priority review of blood substitute
Date: Thu, 30 Oct 2008 14:16:39 GMT
Tags:
Northfield seeks FDA priority review of blood substitute
SmartBrief - Oct 30, 2008
SmartBrief - Oct 30, 2008
Northfield Laboratories filed for FDA priority evaluation of PolyHeme, an investigational blood substitute. The company submitted its request despite data from a clinical trial last year showing ...
BRIEF: Northfield asks FDA for quick PolyHeme review
Date: Thu, 30 Oct 2008 11:16:48 GMT
Tags:
BRIEF: Northfield asks FDA for quick PolyHeme review
Trading Markets (press release) - Oct 30, 2008
Trading Markets (press release) - Oct 30, 2008
Oct 30, 2008 (Chicago Tribune - McClatchy-Tribune Information Services via COMTEX) -- NFLD | Quote | Chart | News | PowerRating -- In a race against the clock to get US approval of its only ...
Northfield Laboratories Inc. Announces Submission of BLA for PolyHeme ®
Date: Wed, 29 Oct 2008 15:01:48 GMT
Tags:
Northfield Laboratories Inc. Announces Submission of BLA for PolyHeme ®
Business Wire (press release) - Oct 29, 2008
Northfield Laboratories files BLA for PolyHeme - Trading Markets (press release)
Business Wire (press release) - Oct 29, 2008
EVANSTON, Ill.--(BUSINESS WIRE)--Northfield Laboratories Inc. (Nasdaq: NFLD) announced today it has submitted a Biologics License Application (BLA) to the Food and Drug Administration (FDA) for ...
Northfield Laboratories Inc. Announces Submission of BLA for PolyHeme(R) - PR-Inside.com (Pressemitteilung)Northfield Laboratories files BLA for PolyHeme - Trading Markets (press release)
Northfield Laboratories Inc. Announces Submission of BLA for PolyHeme(R) (Business Wire)
Date: Wed, 29 Oct 2008 14:55:00 Etc/GMT
Tags:
Northfield Laboratories Presentation at the Rodman & Renshaw 10th Annual Healthcare Conference to Be Webcast Live (Business Wire)
Date: Tue, 28 Oct 2008 11:00:00 Etc/GMT
Tags:
EVANSTON, Ill.----Northfield Laboratories Inc. announced today that Steven A. Gould, M.D., Chairman and Chief Executive Officer, will be presenting at the Rodman & Renshaw 10thAnnual Healthcare Conference on Tuesday, November 11, 2008, at 3:15 p.m.
NORTHFIELD LABORATORIES INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
Date: Fri, 24 Oct 2008 20:03:38 Etc/GMT
Tags:
NORTHFIELD LABORATORIES INC /DE/ Financials (EDGAR Online Financials)
Date: Thu, 16 Oct 2008 13:04:21 Etc/GMT
Tags:
Northfield Laboratories Inc. Reports Fiscal 2009 First Quarter Financial Results (Business Wire)
Date: Fri, 10 Oct 2008 20:44:00 Etc/GMT
Tags:
EVANSTON, Ill.----Northfield Laboratories Inc. announced today financial results for the first fiscal quarter ended August 31, 2008.